Ascendis Pharma
Ascendis Pharma is applying its innovative TransCon technologies to build a leading, fully integrated biopharmaceutical company focused on making a meaningful.
Launch date
Employees
Market cap
$6.5b
Enterprise valuation
$7.0b (Public information from Sep 2024)
Share price
$148.88 ASND
Company register number HRB 337385 (Mannheim)
Gentofte Municipality Capital Region of Denmark (HQ)
Authorizing premium user...